BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Xenon Pharmaceuticals Inc. (Formerly Xenon Genetics) 

3650 Gilmore Way

Burnaby  British Columbia  V5G 4W8  Canada
Phone: 604-484-3300 Fax: 604-484-3450


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Genomics





 Company News
Xenon Pharmaceuticals Inc. Appoints Steven Gannon To Its Board Of Directors 5/22/2015 7:04:22 AM
Xenon Pharmaceuticals Inc. Reports First Quarter 2015 Financial Results And Provides Corporate Update 5/13/2015 8:52:41 AM
Xenon Pharmaceuticals Inc. To Host Conference Call And Webcast To Discuss First Quarter 2015 Financial Results And Provide Corporate Update 5/8/2015 8:10:22 AM
Teva (TEVA) And Xenon Pharmaceuticals Inc. Announce Enrollment Of First Patient In A Phase 2b Study Evaluating TV-45070 For Postherpetic Neuralgia (PHN) 4/2/2015 7:08:09 AM
Xenon Pharmaceuticals Inc. Appoints Dr. Richard H. Scheller To Its Board Of Directors 3/16/2015 8:02:07 AM
Xenon Pharmaceuticals Inc. Reports 2014 Financial Results And Provides Corporate Update 3/13/2015 7:20:43 AM
Xenon Pharmaceuticals Inc. Partner Teva Pharmaceutical Industries (TEVA) To Initiate Phase 2b Clinical Trial Of TV-45070 In Post-Herpetic Neuralgia 2/20/2015 7:13:19 AM
Xenon Pharmaceuticals Inc. Outlines Key Anticipated Milestones For 2015 1/8/2015 8:03:43 AM
Xenon Pharmaceuticals Inc. Reports Third Quarter 2014 Financial Results 12/15/2014 8:15:15 AM
Xenon Pharmaceuticals Inc. Announces Closing Of Initial Public Offering And Full Exercise Of The Underwriters' Option To Purchase Additional Shares 11/11/2014 7:32:14 AM
1234